| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.21 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |